nipradilol has been researched along with Glaucoma in 8 studies
*Glaucoma: An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed) [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arai, K; Kamiya, M; Kato, S; Koriyama, Y; Ogai, K; Sugitani, K | 1 |
| Hara, Y; Matsuura, T; Morishita, K; Nitta, N; Taketani, F; Yukawa, E | 1 |
| Ando, A; Ito, S; Kaneko, S; Matsumura, M; Miyake, M; Nambu, R; Okuda-Ashitaka, E; Okumura, T; Taomoto, M; Unezaki, S; Yamazaki, Y | 1 |
| Kimura, I | 1 |
| Nakamura, M; Sagawa, H; Terasaki, H; Tokita, Y; Watanabe, M; Yata, T | 1 |
| Ayajiki, K; Kitamura, Y; Okamura, T; Toda, M; Toda, N; Uchiyama, M | 1 |
| Masuda, K | 1 |
| Koibuchi, H; Koseki, Y; Nagataki, S; Yamakawa, R | 1 |
2 review(s) available for nipradilol and Glaucoma
| Article | Year |
|---|---|
Medical benefits of using natural compounds and their derivatives having multiple pharmacological actions.
Topics: Adrenergic Antagonists; Angiogenesis Inhibitors; Animals; Antihypertensive Agents; Atractylodes; Diabetes Complications; Diabetes Mellitus, Type 2; Drug Design; Glaucoma; Glycoside Hydrolases; Gymnema sylvestre; Humans; Hypoglycemic Agents; Nicotinic Antagonists; Propanolamines; Saponins; Sesquiterpenes, Eudesmane; Structure-Activity Relationship; Triterpenes | 2006 |
[Current topics in glaucoma].
Topics: Adult; Animals; Female; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Male; Mitomycin; Propanolamines; Prostaglandins F, Synthetic | 1996 |
1 trial(s) available for nipradilol and Glaucoma
| Article | Year |
|---|---|
[Effect of nipradilol on aqueous flow in glaucoma patients treated with timolol].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aqueous Humor; Female; Glaucoma; Glaucoma, Open-Angle; Humans; Male; Middle Aged; Propanolamines; Timolol | 1997 |
5 other study(ies) available for nipradilol and Glaucoma
| Article | Year |
|---|---|
Nipradilol promotes axon regeneration through S-nitrosylation of PTEN in retinal ganglion cells.
Topics: Adrenergic beta-Antagonists; Animals; Cell Line, Transformed; Glaucoma; Mice; Nerve Regeneration; Nitric Oxide; Propanolamines; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Rats; Retinal Ganglion Cells; Signal Transduction; TOR Serine-Threonine Kinases | 2014 |
[Long-term study of nipradilol ophthalmic solution in patients with normal-tension glaucoma].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Female; Glaucoma; Humans; Male; Middle Aged; Ophthalmic Solutions; Propanolamines | 2008 |
Cytoprotection by nipradilol, an anti-glaucomatous agent, via down-regulation of apoptosis related gene expression and activation of NF-kappaB.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Carrier Proteins; Caspase 9; Caspases; Down-Regulation; Gene Expression Regulation; Glaucoma; Mitochondrial Proteins; NF-kappa B; PC12 Cells; Polymerase Chain Reaction; Propanolamines; Proto-Oncogene Proteins c-bcl-2; Rats; Translocation, Genetic | 2005 |
Survival and axonal regeneration of off-center retinal ganglion cells of adult cats are promoted with an anti-glaucoma drug, nipradilol, but not BDNF and CNTF.
Topics: Age Factors; Animals; Antihypertensive Agents; Axons; Brain-Derived Neurotrophic Factor; Cats; Cell Count; Cell Shape; Cell Survival; Ciliary Neurotrophic Factor; Ciliary Neurotrophic Factor Receptor alpha Subunit; Dendrites; Denervation; Glaucoma; Graft Survival; Nerve Regeneration; Optic Nerve Injuries; Propanolamines; Receptor, trkB; Recovery of Function; Retinal Ganglion Cells | 2007 |
Canine retinal arterial and arteriolar dilatation induced by nipradilol, a possible glaucoma therapeutic.
Topics: Animals; Arterioles; Dogs; Female; Glaucoma; In Vitro Techniques; Male; Muscle Relaxation; Propanolamines; Retinal Artery; Vasodilator Agents | 1996 |